A pH-responsive cocktail paclitaxel/doxorubicin nanocapsule with suitable size (around 100 nm), good biocompatibility and good cell targeting is developed via the assembly of poly(amino acid) for synergetic chemotherapy of cancers.
No takes yet. Share an insight, caveat, or question.
He et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: